亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Breaking Down Barriers to a Suicide Prevention Helpline: Web-Based Randomized Controlled Trial

帮助热线 随机对照试验 毒物控制 医学 自杀预防 干预(咨询) 考试(生物学) 自杀意念 心理学 精神科 医疗急救 外科 急诊医学 古生物学 生物
作者
Margot C. A. van der Burgt,Saskia Mérelle,Willem‐Paul Brinkman,Aartjan T.F. Beekman,Renske Gilissen
出处
期刊:JMIR mental health [JMIR Publications]
卷期号:11: e56396-e56396 被引量:1
标识
DOI:10.2196/56396
摘要

Abstract Background Every month, around 3800 people complete an anonymous self-test for suicidal thoughts on the website of the Dutch suicide prevention helpline. Although 70% score high on the severity of suicidal thoughts, <10% navigate to the web page about contacting the helpline. Objective This study aimed to test the effectiveness of a brief barrier reduction intervention (BRI) in motivating people with severe suicidal thoughts to contact the suicide prevention helpline, specifically in high-risk groups such as men and middle-aged people. Methods We conducted a fully automated, web-based, randomized controlled trial. Respondents with severe suicidal thoughts and little motivation to contact the helpline were randomly allocated either to a brief BRI, in which they received a short, tailored message based on their self-reported barrier to the helpline (n=610), or a general advisory text (care as usual as the control group: n=612). Effectiveness was evaluated using both behavioral and attitudinal measurements. The primary outcome measure was the use of a direct link to contact the helpline after completing the intervention or control condition. Secondary outcomes were the self-reported likelihood of contacting the helpline and satisfaction with the received self-test. Results In total, 2124 website visitors completed the Suicidal Ideation Attributes Scale and the demographic questions in the entry screening questionnaire. Among them, 1222 were randomized into the intervention or control group. Eventually, 772 respondents completed the randomized controlled trial (intervention group: n=369; control group: n=403). The most selected barrier in both groups was “I don’t think that my problems are serious enough.” At the end of the trial, 33.1% (n=122) of the respondents in the intervention group used the direct link to the helpline. This was not significantly different from the respondents in the control group (144/403, 35.7%; odds ratio 0.87, 95% CI 0.64‐1.18, P =.38). However, the respondents who received the BRI did score higher on their self-reported likelihood of contacting the helpline at a later point in time (B=0.22, 95% CI 0.12‐0.32, P ≤ .001) and on satisfaction with the self-test (B=0.27, 95% CI 0.01‐0.53, P =.04). For male and middle-aged respondents specifically, the results were comparable to that of the whole group. Conclusions This trial was the first time the helpline was able to connect with high-risk website visitors who were hesitant to contact the helpline. Although the BRI could not ensure that those respondents immediately used the direct link to the helpline at the end of the trial, it is encouraging that respondents indicated that they were more likely to contact the helpline at a later point in time. In addition, this low-cost intervention provided greater insight into the perceived barriers to service. Follow-up research should be focused on identifying the added value of other components (eg, video or photo material) in the BRI and increasing its effectiveness, especially for men and middle-aged people.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李爱国应助冷静初蓝采纳,获得10
11秒前
humorlife完成签到,获得积分10
15秒前
现代的冰海完成签到,获得积分10
16秒前
zyyicu完成签到,获得积分10
16秒前
23秒前
yayaya完成签到 ,获得积分10
31秒前
木华月半月半完成签到,获得积分10
34秒前
yyy2025发布了新的文献求助150
34秒前
一剑白发布了新的文献求助10
46秒前
一剑白发布了新的文献求助10
1分钟前
1分钟前
楠屿发布了新的文献求助80
1分钟前
1分钟前
CodeCraft应助科研通管家采纳,获得10
1分钟前
一剑白发布了新的文献求助10
1分钟前
Nancy0818完成签到 ,获得积分0
1分钟前
1分钟前
心无杂念完成签到 ,获得积分10
1分钟前
2分钟前
2分钟前
一剑白发布了新的文献求助10
2分钟前
Marciu33完成签到,获得积分10
2分钟前
2分钟前
Marciu33发布了新的文献求助10
2分钟前
2分钟前
冷静初蓝发布了新的文献求助10
2分钟前
科研通AI6.2应助yyy2025采纳,获得10
2分钟前
冷静初蓝完成签到,获得积分10
2分钟前
2分钟前
yyy2025发布了新的文献求助10
3分钟前
SciGPT应助科研通管家采纳,获得10
3分钟前
科研通AI6.2应助yyy2025采纳,获得10
3分钟前
熬夜冠军完成签到,获得积分20
4分钟前
4分钟前
熬夜冠军关注了科研通微信公众号
4分钟前
sndurehfcn发布了新的文献求助10
4分钟前
謓言完成签到,获得积分10
4分钟前
ebgjaghg发布了新的文献求助10
4分钟前
雪满头应助謓言采纳,获得10
5分钟前
科研通AI2S应助科研通管家采纳,获得10
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
Treatment of refractory idiopathic overactive bladder with incobotulinumtoxinA and vibe delivery system (XAVIER): pilot study 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6947285
求助须知:如何正确求助?哪些是违规求助? 8632161
关于积分的说明 18307420
捐赠科研通 6385253
什么是DOI,文献DOI怎么找? 3080413
关于科研通互助平台的介绍 2123049
邀请新用户注册赠送积分活动 2057325